Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

The ability to compare the volumes of patients’ brain structures to brain structure volumes of healthy controls is a powerful tool to help physicians assess possible existence of neurodegeneration or the progression of a neurodegenerative disorder.

To adjust for any variation in brain size, sex difference, and inter-individual head-size in a population, brain structure volumes are normalized (or scaled) to a common measurement.

Cortechs.ai’ quantitative imaging software uses Intracranial Volume (ICV) to normalize an individual’s brain structure volumes, and automatically calculates it during the post-processing of brain MRIs for volumetric analysis. This consistent measure gives clinicians additional context of their patient’s brain structure volumes, regardless of head size.

ICV, also known as TIV (Total Intracranial Volume), is the volume of the cranial cavity as taken from a 3D T1 MRI, as outlined by the supratentorial dura matter, or cerebral contour when dura is not clearly detectable.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products
Example of segmentation with intracranial mask from T1-weighted image. Image credit: Malone, I.B. et al. (2015). Accurate Automatic Estimation of Total Intracranial Volume: A Nuisance Variable with Less Nuisance. NeuroImage 104 (366-372).

ICV is a very consistent measure across the lifespan of a patient, making it a reliable tool for correction of head size variation across individuals. This correction is especially helpful when assessing neurodegenerative conditions.

For example, Patient A and Patient B both have thalamic volumes that are consistent with the average for their age and sex-matched population. Patient A is 5’6” tall, with an average head circumference, while Patient B is 6’2” tall with an above average head circumference. If the thalamic volumes could be interpreted without correcting for ICV, both patients would yield a normal result. However, once the patient’s thalamic volumes are normalized to their individual ICV, it could become apparent that Patient B’s thalamic volume is lower than expected for their age and gender.

NeuroQuant reports provide brain structure volumes (relevant to the report), % ICV and normative percentiles. NeuroQuant automatically calculates the ICV to accurately compare an individual’s brain structure volumes to Cortechs.ai’ age and sex-matched normative reference data. The ICV normalization and reference comparison on NeuroQuant reports provide physicians with a framework to better understand brain structure volumes when assessing patients.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Need more information about ICV or Cortechs.ai quantitative image products? Contact us.

 

More Resources

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.

05/26/2026

ASNR 2026 Highlights the Growing Role of Quantitative Imaging in Neurology

ASNR 2026 brought together leaders across neuroradiology, imaging AI, and neurological care to explore the future of quantitative imaging.

05/11/2026

Better Models, Better Care: Inside Our Latest Brain Tumor Update

Explore how NeuroQuant® Brain Tumor v2.1 advances AI-powered brain tumor segmentation and clinical workflows.
Scroll to Top